EdgarLookup

Ernexa Therapeutics Inc. — 4 Filings

463 4 filings on record

This page lists all 4 filings submitted to the SEC by Ernexa Therapeutics Inc. (ERNAW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Ernexa Therapeutics Inc. has filed 463 4 documents with the SEC since 2009. To view all SEC filings by Ernexa Therapeutics Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-Q 10-Q/A 15-12G 25 3 3/A 4 4/A 424B3 424B5 425 5 8-A12B 8-A12B/A 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DEFS14A DRS EFFECT NT 10-K NT 10-K/A NT 10-Q POS AM PRE 14A PRES14A REGDEX RW S-1 S-1/A S-3 S-3/A S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
4 OWNERSHIP DOCUMENT 0001104659-26-016680 Feb 17, 2026 Feb 10, 2026
4 0001641172-25-018063 Jul 7, 2025 Jun 21, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058644 Jun 11, 2025 Jun 9, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-032060 Apr 4, 2025 Apr 2, 2025
4 0001493152-25-005721 Feb 10, 2025 Feb 7, 2025
4 0001493152-25-005720 Feb 10, 2025 Feb 7, 2025
4 0001493152-25-005722 Feb 10, 2025 Feb 7, 2025
4 0001493152-25-005718 Feb 10, 2025 Feb 7, 2025
4 0001493152-25-005719 Feb 10, 2025 Feb 7, 2025
4 0001493152-25-002206 Jan 14, 2025 Jan 13, 2025
4 OWNERSHIP DOCUMENT 0001104659-24-114222 Nov 5, 2024 Sep 23, 2024
4 0001493152-24-025105 Jun 25, 2024 Jun 21, 2024
4 FORM 4 0001140361-24-023011 Apr 29, 2024 Apr 26, 2024
4 FORM 4 0001140361-24-023012 Apr 29, 2024 Apr 26, 2024
4 FORM 4 0001140361-24-023013 Apr 29, 2024 Apr 26, 2024
4 FORM 4 0001140361-24-000468 Jan 3, 2024 Jan 1, 2024
4 0001140361-24-000469 Jan 3, 2024 Jan 1, 2024
4 OWNERSHIP DOCUMENT 0001104659-23-127551 Dec 20, 2023 Dec 14, 2023
4 4 0000950170-23-071263 Dec 18, 2023 Dec 14, 2023
4 OWNERSHIP DOCUMENT 0001104659-23-095434 Aug 25, 2023 Jul 13, 2023
4 0001493152-23-027612 Aug 10, 2023 Aug 8, 2023
4 0001493152-23-027615 Aug 10, 2023 Aug 8, 2023
4 0001140361-23-034994 Jul 18, 2023 Jul 14, 2023
4 0001140361-23-034995 Jul 18, 2023 Jul 14, 2023
4 FORM 4 SUBMISSION 0000899243-23-017414 Jul 18, 2023 Jul 14, 2023
4 0001140361-23-031258 Jun 23, 2023 Jun 21, 2023
4 0001140361-23-001698 Jan 13, 2023 Jan 12, 2023
4 0001140361-22-044631 Dec 6, 2022 Dec 2, 2022
4 0001140361-22-044639 Dec 6, 2022 Dec 2, 2022
4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023351 Dec 5, 2022 Dec 2, 2022
4 FORM 4 0001140361-22-034312 Sep 21, 2022 Sep 20, 2022
4 FORM 4 0001140361-22-028095 Aug 3, 2022 Aug 1, 2022
4 FORM 4 0001140361-22-028093 Aug 3, 2022 Aug 1, 2022
4 FORM 4 0001140361-22-028096 Aug 3, 2022 Aug 1, 2022
4 FORM 4 0001140361-22-028097 Aug 3, 2022 Aug 1, 2022
4 FORM 4 0001140361-22-028094 Aug 3, 2022 Aug 1, 2022
4 FORM 4 0001140361-22-024524 Jun 29, 2022 Jun 28, 2022
4 FORM 4 0001140361-22-023928 Jun 23, 2022 Jun 21, 2022
4 FORM 4 0001140361-22-022025 Jun 6, 2022 Jun 3, 2022
4 FORM 4 0001140361-22-009663 Mar 15, 2022 Mar 11, 2022
4 FORM 4 0001140361-22-009660 Mar 15, 2022 Mar 11, 2022
4 FORM 4 0001140361-22-009664 Mar 15, 2022 Mar 11, 2022
4 FORM 4 0001140361-22-009661 Mar 15, 2022 Mar 11, 2022
4 FORM 4 0001140361-22-009662 Mar 15, 2022 Mar 11, 2022
4 FORM 4 0001140361-22-002077 Jan 19, 2022 Jan 14, 2022
4 FORM 4 0001140361-22-002078 Jan 19, 2022 Jan 14, 2022
4 FORM 4 0001140361-21-041284 Dec 10, 2021 Dec 8, 2021
4 FORM 4 0001140361-21-041285 Dec 10, 2021 Dec 8, 2021
4 FORM 4 0001140361-21-041286 Dec 10, 2021 Dec 8, 2021
4 FORM 4 0001140361-21-041287 Dec 10, 2021 Dec 8, 2021